Determinants of Willingness for COVID-19 Vaccine: Implications for Enhancing the Proportion of Vaccination Among Indians.
acceptance
covid vaccine
hesitancy
unwillingness
willingness
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
27 May 2021
27 May 2021
Historique:
entrez:
1
7
2021
pubmed:
2
7
2021
medline:
2
7
2021
Statut:
epublish
Résumé
Objective To assess willingness for the coronavirus disease 2019 (COVID-19) vaccine and identify the factors attributing to the willingness. Design A cross-sectional study was conducted, adopting an exponential, non-discriminative snowball sampling technique. The questionnaire collected the socio-demographic profile, history of COVID-19 infection, presence of co-morbidities (diabetes mellitus, hypertension, chronic obstructive pulmonary disease (COPD), asthma, cancer), willingness, and preference of vaccine among participants. An online platform (Google Forms) was used to collect data from all over India. A total of 2032 Indian adults aged above 18 years were included in the study. Results Around 1598 (78.6%) expressed willingness to receive the COVID vaccine, and among the healthcare providers (HCPs), 579 (80.3%) were willing for COVID vaccination. Factors like the belief that the vaccine is necessary (aOR=1.68, 95% CI =1.34 to 2.11), respondents having no history of COVID infection (aOR=0.71, 95% CI: 0.52 to 0.97), having trust in the government (aOR=6.09, CI: 4.59 to 7.98), people who felt the cost of the vaccine didn't matter (aOR=4.92, CI: 3.80 to 6.37), and respondents with no perceived risk of COVID infection (aOR=0.63; CI: 0.47 to 0.83) were more associated with willingness for COVID vaccination. Conclusions An effective vaccine should be well-received by the public. The responsibility lies with the government, health authorities, and manufacturers to take appropriate steps to dispel rumors in order to ensure people's understanding and acceptance.
Identifiants
pubmed: 34194875
doi: 10.7759/cureus.15271
pmc: PMC8234562
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e15271Informations de copyright
Copyright © 2021, Jacob et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
Hum Vaccin Immunother. 2015;11(10):2376-88
pubmed: 26110454
Vaccine. 2011 Sep 2;29(38):6472-84
pubmed: 21756960
Osong Public Health Res Perspect. 2020 Aug;11(4):149-157
pubmed: 32864304
Nat Med. 2021 Feb;27(2):225-228
pubmed: 33082575
Vaccines (Basel). 2020 Aug 27;8(3):
pubmed: 32867224
PLoS Negl Trop Dis. 2020 Dec 17;14(12):e0008961
pubmed: 33332359
J Multidiscip Healthc. 2020 Nov 20;13:1657-1663
pubmed: 33262600
Indian J Med Res. 2013 Feb;137(2):388-90
pubmed: 23563384
Lancet Reg Health Eur. 2021 Feb;1:100012
pubmed: 33954296
J Glob Health. 2021 Jan 13;11:03002
pubmed: 33643614
J Family Med Prim Care. 2019 Dec 10;8(12):3949-3955
pubmed: 31879642
EClinicalMedicine. 2020 Sep;26:100495
pubmed: 32838242
Influenza Res Treat. 2012;2012:753164
pubmed: 23251794
Front Public Health. 2020 Jul 14;8:381
pubmed: 32760691